Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Alzheimer’s disease and related dementias

Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease.

Wen-Dai Bao; Pei Pang; Xiao-Ting Zhou; Fan Hu; Wan Xiong; Kai Chen; Jing Wang; Fudi Wang; Dong Xie; Ya-Zhuo Hu; Zhi-Tao Han; Hong-Hong Zhang; Wang-Xia Wang; Peter T Nelson; Jian-Guo Chen; Youming Lu; Heng-Ye Man; Dan Liu; Ling-Qiang Zhu

Originally published in Cell death and differentiation · 2021-01-04

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Iron homeostasis disturbance has been implicated in Alzheimer's disease (AD), and excess iron exacerbates oxidative damage and cognitive defects. Ferroptosis is a nonapoptotic form of cell death dependent upon intracellular iron. However, the involvement of ferroptosis in the pathogenesis of AD remains elusive. Here, we report that ferroportin1 (Fpn), the only identified mammalian nonheme iron exporter, was downregulated in the brains of APPswe/PS1dE9 mice as an Alzheimer's mouse model and Alzheimer's patients. Genetic deletion of Fpn in principal neurons of the neocortex and hippocampus by breeding Fpn fl/fl mice with NEX-Cre mice led to AD-like hippocampal atrophy and memory deficits. Interestingly, the canonical morphological and molecular characteristics of ferroptosis were observed in both Fpn fl/fl/NEXcre and AD mice. Gene set enrichment analysis (GSEA) of ferroptosis-related RNA-seq data showed that the differentially expressed genes were highly enriched in gene sets associated with AD. Furthermore, administration of specific inhibitors of ferroptosis effectively reduced the neuronal death and memory impairments induced by Aβ aggregation in vitro and in vivo.

Discussion

Recently, excess deregulated brain iron has been widely reported in the pathogenesis of neurodegenerative diseases such as Parkinson’s disease (PD) [45], Huntington’s disease [46], amyotrophic lateral sclerosis (ALS) [47], and Alzheimer’s disease (AD) [1, 48]. However, the underlying mechanisms and roles of iron regulation associated genes in the disturbance of iron homeostasis remain elusive. Here, we demonstrated that Fpn, the only known iron exporter, was downregulated with age in an AD mouse model and AD patients, consistent with multiple previous reports [25, 49, 50].

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?